Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Jury finds PeaceHealth, ER doctor not liable for misdiagnosing patient’s stroke
After a three week trial, a jury found that PeaceHealth and Ralph Weiche, MD, acted in accordance with medical protocols in diagnosing Patricia Parker with a psychiatric condition, given her unusual symptoms.
Best Buy Health sells at-home tech company back to founder
Current Health—purchased by Best Buy for $400 million in 2021—is set to become an independent company again, with co-founder Christopher McGhee taking over. The electronics retailer appears to be backing away from remote patient monitoring services, shifting its healthcare division's focus to consumer products that improve the lives of seniors.
DOJ announces 324 arrests in $14.6B healthcare fraud crackdown
Of those arrested, 96 are doctors, nurses and other healthcare providers. All face charges related to telehealth prescriptions, illegal opioid distribution and fraudulent billing practices.
Private equity firm jumps into vascular health with new investment
Vascular Technology, first founded 40 years ago, is planning on using the new funds to grow and expand its portfolio.
At a crossroads: Surgical heart valve innovation slows as transcatheter treatments keep evolving
Has the success of TAVR and other interventional techniques had a negative impact on surgical valve innovation? Two surgeons shared their concerns in a new commentary.

Cordis has received U.S. Food and Drug Administration (FDA) approval for its new MYNX Control Venous Vascular Closure Device (VCD) for 6F-12F access sites. The company hopes to launch the newly approved extravascular closure device in the months ahead.

Cordis gains FDA approval for new closure device, inks pricing deal with Premier

The newly approved extravascular closure device was designed for procedures with access sites from 6 to 12 French. It uses the same proprietary GRIP technology found in other Cordis interventional devices.

How the proposed Medicare Physician Fee Schedule could impact nuclear cardiology

The American Society of Nuclear Cardiology explored some key points included in the 2025 Medicare Physician Fee Schedule proposed rule.

Radiologist questions the benefit of sharing online ratings of rads without ‘guidelines and guardrails’

Julianna Czum, MD, of Johns Hopkins Medicine, made her case in the American Journal of Roentgenology on Wednesday, with 2 Utah rads issuing a rebuttal.

Radiology Partners discusses its research priorities

The RP Research Institute is an affiliation between the country's largest imaging group and some of the top academic institutions in the U.S.

Industry Watcher’s Digest

Buzzworthy developments of the past few days: Mayo Clinic leads the league in AI readiness

healthcare money economics dollar stethoscope acquire merger

Private equity firms back less than 4% of healthcare providers, report finds

According to an analysis from PitchBook, providers backed by private equity make up only 3.3% of the total market by revenue.

Gallup: 45% of adults cannot afford the care they need

A survey from West Health and Gallup found fewer Americans can now afford premiums, copays, prescriptions and medical bills, with numbers falling across all age demographics since 2022.

Tech companies team up to help cardiologists reach high-risk heart patients

Guidehealth and Story Health are joining forces to put AI-powered technology in the hands of heart teams.

Management

Jury finds PeaceHealth, ER doctor not liable for misdiagnosing patient’s stroke

Best Buy Health sells at-home tech company back to founder

DOJ announces 324 arrests in $14.6B healthcare fraud crackdown

Private equity firm jumps into vascular health with new investment

At a crossroads: Surgical heart valve innovation slows as transcatheter treatments keep evolving